Cite
HARVARD Citation
Ghonem, N. et al. (2020). Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol. Clinical pharmacology & therapeutics. 108 (6), pp. 1213-1223. [Online].